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ABSTRACT 
Twenty derivatives of isatin (1H-indole-2, 3-Dione) were synthesized by the schematic route as per as scheme. These were further 
characterized by spectroscopic analysis. All the novel synthesized derivatives of isatin were screened for their antimicrobial activity against 
Gram-positive bacteria: Staphylococcus aureus, Bacillus subtilis, Streptococcus pneumonia; Gram-negative bacteria: Escherichia coli, 
Pseudomonas aeruginosa, Klebsiella pneumoniae and fungal strains: Candida albicans, Aspergillus niger, Penicillium chrysogenum, Rhizopus 
oryzae by cup-plate method. Results of antimicrobial screening showed that compound ID5, ID9, ID15 and ID18 possess potent antibacterial 
activity. Whereas ID1, ID3, ID4, ID7 and ID20 possess antifungal activity comparable to standard drugs.  
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1. INTRODUCTION 
There are several heterocyclic compounds but five and six 
membered ring compounds have gained a special place 
among different classes of organic compounds for their 
versatile and diversified biological activities1.  Among all the 
variety of heterocycles that have been identified for 
producing pharmaceutically valuable molecules, indoles and 
oxadiazines have shown a remarkable role in pharmaceutical 
chemistry2. 
Isatin is a heterocyclic compound having indole ring system. 
Isatin mainly reacts at three different sites, namely aromatic 
substitution at C-5, N-alkylation, and carbonyl reactions at C-
3. If the system carries electron-withdrawing groups in the 
benzene ring or at the nitrogen, attacks at C-2 can also 
occur3. Nitration of isatin yields 5-nitroisatin, where the 
reaction proceeds smoothly at 0  but the temperature 
needs to be controlled precisely or else the nitration will give 
rise to several nitrated products4-6. Nevertheless, 5, 7-
dinitroisatin can be synthesized by merely heating 3,3,5,7-
tetranitrooxindole, which in turn can be obtained from the 
nitration of oxindole7. When bromine is added to a solution 
of isatin in ethanol it yields dibrominated product 5,7-
dibromoisatin8. Nevertheless mono bromination at C-5 could 
be achieved by treatment of isatin with N-bromosuccinimide, 
while 5-chloroisatin by using N-chlorosuccinimide9. A few 
years ago, mono iodination of isatin yielding 5-iodoisatin was 
achieved by using an aqueous potassium dichloroiodate 
(KICl2) as the iodinating agent10. 
Commonly, N-alkylation of isatin proceeds via the sodium 
salt of isatin, which reacts with appropriate alkyl halide or 
alkyl sulfonate. Methylation can also be achieved with other 
reagents, for example potassium tert-butoxide and dimethyl 
oxalate (60% yield)11. However, normal alkylation conditions 
such as dimethyl sulfate in ethanolic potassium hydroxide 
(80% yield) or benzylation with sodium hydride and benzyl 
bromide (90% yield) give better yields12-13. 
N-aceylation can be acheived by heating isatin in acetic 
anhydride for a couple of hours, although a modified 
procedure (sodium acetate and isatin heated shortly in acetic 
anhydride) has been published14-15. Protecting amines as N-
carbamates is a commonly adopted strategy, which has also 
been applied to isatin. N-Boc isatin and N-CBz isatin have 
been synthesized in 89% and 85% yield, respectively16-17. 
All ketones, as well as, the C-3 carbonyl group of isatin were 
susceptible towards nucleophiles. Ketalisation serves this 
perfectly, as a good example of nucleophilic attack on the 
carbonyl functionality. Thus, employing ethylene glycol, 1, 2-
ethanedithiol or 2-mercapto ethanol on isatin yields different 
spiro ketals of oxindole18-20. Though, the example above 
considers heteroatom dinucleophiles, carbon nucleophiles 
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do also react at C-3. Grignard reagents also attack at C-3 and 
yield the 3-hydroxy-3-substituted oxindoles, which readily 
can be reduced to 3-substituted indoles21. 
On the basis of above literature survey, we have planned the 
present scheme for the synthesis of different isatin 
derivatives with different pharmacological activities. 
2. MATERIALS AND METHODS 
All the chemicals used in the synthesis of isatin derivatives 
were of synthetic grade and procured locally. Thin layer 
chromatography was used for monitoring the progress of 
reaction and product formation. The thin layer 
chromatography of the synthesized compounds was done on 
precoated TLC (silica gel) plates by using different solvent 
medium. Identification of spots was done under UV lamp and 
in iodine chamber. Detection of spots under UV lamp was 
done at both short and long wavelength. Melting points of 
the synthesized compounds were determined on melting 
point apparatus.  
Experimental 
Step 1-General procedure for synthesis of Intermediates 
Equimolar quantities (0.008 mol) of 5-bromo isatin and p-
bromo aniline were taken in 250ml round bottom flask, 
containing 1 ml of glacial acetic acid and these were 
dissolved in 20 ml of ethanol. It was refluxed for 2 hrs. After 
standing for approximately 24 hours at room temperature, 
the product was separated by filtration, washed with sodium 
bisulfite solution to remove excess of aldehyde, vacuum 
dried and recrystallized with ethanol. 
Step 2-General procedure for synthesis of Mannich base 
derivatives 
Equimolar quantities (0.004 mol) of diphenylamine in 10 ml 
ethanol was taken in a 250ml round bottom flask and to this 
added a slurry containing appropriate compound obtained 
from step 1 and 0.3ml of formaldehyde solution (37%v/v) in 
10ml of ethanol. The mixture was stirred for 2 hrs at room 
temperature and refrigerated for 48 hours. The product was 
separated by filtration and vacuum dried. Recrystallization 
was done with ethanol. 
Step 3-General procedure for synthesis of isatin 
derivatives (ID1-ID20) 
Equimolar quantities (0.008 mol) of p-methyl aniline and 
step 2 product were taken in 250ml round bottom flask, 
containing 1 ml of glacial acetic acid and these were 
dissolved in 20 ml of ethanol. Refluxed it for 2 hrs. After 
standing for approximately 24 hours at room temperature, 
the product was separated by filtration, washed with sodium 
bisulfite solution to remove excess of aldehyde, vacuum 
dried and recrystallized with ethanol. 
 
Scheme-1 Synthesis of Istain derivatives (ID1-ID20) 
 
 
Physicochemical property prediction of synthesized 
derivatives (ID1-ID20) 
A variety of molecular properties like Log P, molar 
refractivity and topological polar surface area were 
calculated for both standard drugs and target compounds by 
using Chem 3D Ultra version 12.0.2, software program. The 
observations are as follows in Table 1. 
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Table 1: Molecular properties of the synthesized isatin derivatives (ID1-ID20) 
Compound Code Molecular Formula MWx MRy tPSAz Log P 
ID1 C26H27N5O2 441.52 NC 83.01 4.00 
ID2 C25H21BrN4O4 521.36 131.36 105.80 5.64 
ID3 C26H27N4F 414.52 125.97 31.20 7.02 
ID4 C26H27N4Br 475.42 133.26 31.20 7.69 
ID5 C33H23N4Br2F 654.37 164.11 31.20 11.01 
ID6 C21H15N3OBr2 485.17 114.44 45.98 6.41 
ID7 C21H13N4O4Br 465.26 NC 125.86 4.17 
ID8 C21H13N3O2Cl2 410.25 107.83 74.05 5.56 
ID9 C21H15N3ClOF 379.81 104.06 45.98 5.47 
ID10 C22H17N3Br2 483.20 117.69 36.75 7.44 
ID11 C18H18N3Br 356.26 95.51 36.75 5.37 
ID12 C21H16N3F 329.37 98.11 36.75 5.53 
ID13 C34H26N4Br2 650.41 169.60 31.20 11.34 
ID14 C28H31N5O2 469.58 NC 83.01 4.91 
ID15 C24H20N4O2BrCl 511.80 129.18 68.50 6.64 
ID16 C26H27N4Cl 430.97 130.17 31.20 7.42 
ID17 C28H31N4Br 503.48 142.46 31.20 8.53 
ID18 C27H28N4BrCl 523.90 142.46 31.20 8.67 
ID19 C37H33N4Cl 569.14 173.92 31.20 11.56 
ID20 C33H23N4Br2Cl 670.82 168.31 31.20 11.41 
Ciprofloxacin C17H18N3FO3 331.34 89.39 72.88 1.32 
Fluconazole C13H12N6F2O 306.27 78.46 76.15 0.99 
Abbreviations: x-Molecular weight, y-Molar refractivity, z-Topological polar surface area, NC-Not calculated 
 
In vitro antimicrobial activity 
The antimicrobial assay is based upon a comparison of the 
inhibition of growth of micro-organism by measured 
concentrations of the antimicrobial agents to be examined 
with that procedure by known concentration of standard 
preparation of the antibiotics having a known activity22. 
Six strains of bacteria and four strains of fungi were taken as 
the test organism. In order to evaluate the antibacterial 
spectrum of the prepared compounds,  strains of  Bacillus 
subtillis (MTCC 441), Pseudomonas aeruginosa (MTCC 424), 
Escherichia coli MTCC (1573), Staphylococcus aureus 
(MTCC1430),  Streptococcus pneumoniae (MTCC 655), and 
Klebsiella pneumoniae (MTCC 618),  were procured as pure 
culture from Institute of Microbial Technology, Chandigarh. 
For antifungal spectrum of the prepared compounds, strains 
of Aspergillus niger (MTCC 2546), Rhizopus oryzae (MTCC 
2775), Candida albicans (MTCC 183) and Penicillium 
chrysogenum (MTCC 161), were procured as pure culture 
from Institute of Microbial Technology, Chandigarh. Growth 
media were prepared in accordance with the direction laid 
down in the package insert received from MTCC, Institute of 
Microbial Technology, Chandigarh. 
Evaluation of Antimicrobial Activity 
The test organisms were inoculated in nutrient broth. A 
definite volume of this suspension was mixed with nutrient 
agar (cooled to 40 ). Nutrient agar was poured into 
petridishes to obtain a uniform thickness. The surface of 
agar plates was pierced using a sterile cork borer. The 
prepared wells were filled with equal volumes of a solution 
of antimicrobial agents ID1-ID20. After a period of pre 
incubation diffusion, the plates were incubated face up for a 
definite time and at the specific temperature for that strain. 
The diameters of zones of inhibition were measured and are 
reported in Table 2 and   Table 3. 
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Table 2: Observation of Synthesized Isatin Derivatives for Antibacterial Activity. 
 
Compound 
code 
 
Conc.   
(μg/ml) 
Observation of Antibacterial activity 
Gram –ve Gram +ve 
E.coli P.aeruginosa K.pneumoniae B.subtilis S.aureus S.pneumoniae 
ID1 200 ++ ++ - - - - 
ID2 200 + + ++ + - - 
ID3 200 ++ ++ + - - + 
ID4 200 ++ - ++ - ++ - 
ID5 200 +++ - - ++ - - 
ID6 200 + - - - - + 
ID7 200 ++ ++ - - - - 
ID8 200 + - ++ - ++ - 
ID9 200 +++ - - ++ - - 
ID10 200 + - + - - ++ 
ID11 200 ++ - - + - - 
ID12 200 ++ ++ - - ++ - 
ID13 200 + - ++ - - ++ 
ID14 200 + - + - + - 
ID15 200 +++ - - ++ ++ - 
ID16 200 ++ - - - - + 
ID17 200 + ++ + - ++ - 
ID18 200 +++ - ++ ++ - - 
ID19 200 + + - - + + 
ID20 200 ++ ++ + + - - 
Ciprofloxacin  +++ +++ +++ +++ +++ +++ 
DMF  __ __ __ __ __ __ 
Zones of inhibition for bacteria 
-    = < 6 mm (inactive); +    = 6-9 mm (slightly active); ++ = 9-12 mm (moderately active); +++ = 12-15 mm (highly    active); 
Standard - Ciprofloxacin, Control – DMF   
 
Table 3: Observation of Synthesized Isatin Derivatives for Antifungal activity 
Compound 
code 
Conc. 
(μg/ml) 
Observation of Antifungal activity 
 
A. niger R. oryzae C. albicans P. chrysogenum 
ID1 200 ++ - - - 
ID2 200 - + - + 
ID3 200 ++ - - - 
ID4 200 ++ - + - 
ID5 200 - - - - 
ID6 200 + - - - 
ID7 200 ++ + - - 
ID8 200 - - - - 
ID9 200 ++ - - + 
ID10 200 - - + - 
ID11 200 ++ - - + 
ID12 200 - + - - 
ID13 200 + - - - 
ID14 200 + - + - 
ID15 200 - - - + 
ID16 200 ++ - - - 
ID17 200 - + + - 
ID18 200 ++ - - + 
ID19 200 - + - - 
ID20 200 ++ + + + 
Fluconazole  +++ +++ ++ +++ 
DMF  __ __ __ __ 
Zones of inhibition for fungi 
-  = < 6 mm (inactive); + = 6-9 mm (slightly active); ++ = 9-12 mm (moderately active); +++ = 12-15 mm (highly active); 
      Standard - Fluconazole, Control – DMF   (+) represents the activity while (-) represent do not active. 
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3. RESULTS AND DISCUSSION 
Synthesis of isatin derivatives (ID1-20) has shown in 
general pathway outlined in the Scheme-1. All of the 
derivatives were synthesized in good yield. The structures of 
newly synthesized derivatives were analysed on the basis of 
IR, Mass and 1H NMR (data not shown). The physicochemical 
properties of synthesized derivatives are calculated and 
tabulated in Table 1. The purity of synthesized derivatives 
were checked and monitored by TLC. 
Most of the synthesized derivatives have molar refractivity 
under 150. Topological polar surface area (tPSA) values for 
the synthesized derivatives were found within 31.20-125.86, 
which is a surface sum over all polar atoms, primarily 
oxygen and nitrogen, also their attachment to the hydrogen 
atoms that helps the compound permeation through the 
cell.  Compounds having a polar surface area of greater than 
140 angstroms squared show poor permeating behaviour 
through cell membranes23. The Log P value of synthesized 
derivatives were 4.00-11.56 within the range of standard 
drugs which shows that  a positive value for Log P indicates 
a higher concentration in the lipid phase. This indicates that 
the compounds potentially cross the blood brain barrier. The 
synthesized compounds were tested for their antibacterial 
and antifungal activity against different bacteria and fungi. 
The results got for the same are shown in Table 2 and Table 
3. It is evident from the results of synthesized derivatives 
containing halogen atoms like chloro, bromo and fluoro 
were showing significant antibacterial and antifungal 
activity, which depicts that halogen atoms have an important 
role in antimicrobial activity. On the other hand remaining 
synthesized compounds revealed the variable antibacterial 
and antifungal activity. Among all, synthesized derivatives 
ID5, ID9, ID15 and ID18 possess potent antibacterial activity. 
Whereas ID1, ID3, ID4, ID7 and ID20 possess antifungal 
activity. 
4. CONCLUSION 
In present study, we synthesized the isatin derivatives with 
range of pharmacological activities as antimicrobial agents. 
It has been found that most of the synthesized compounds 
were more potent as compared to the standard, which can 
be used as lead for novel antimicrobial agents. 
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